119 related articles for article (PubMed ID: 2945696)
1. Normal distribution of complement C3b receptor (CR1) numbers on erythrocytes in blood donors: low levels are associated with HLA-B27.
Thomsen BS; Jacobsen SE; Nielsen H; Jakobsen BK; Sørensen H
Complement; 1986; 3(2):79-87. PubMed ID: 2945696
[TBL] [Abstract][Full Text] [Related]
2. Complement C3b receptors on erythrocytes in patients with juvenile rheumatoid arthritis.
Thomsen BS; Heilmann C; Jacobsen SE; Pedersen FK; Morling N; Jakobsen BK; Svejgaard A; Nielsen H
Arthritis Rheum; 1987 Sep; 30(9):967-71. PubMed ID: 2959290
[TBL] [Abstract][Full Text] [Related]
3. Antiglobulin testing for CR1-related (Knops/McCoy/Swain-Langley/York) blood group antigens: negative and weak reactions are caused by variable expression of CR1.
Moulds JM; Moulds JJ; Brown M; Atkinson JP
Vox Sang; 1992; 62(4):230-5. PubMed ID: 1379395
[TBL] [Abstract][Full Text] [Related]
4. Enzyme-linked immunoassay to monitor the purification of, and to screen for monoclonal antibodies against, C3b receptor.
Schulz TF; Helmberg A; Hosp M; Petzer A; Föger B; Dierich MP
Complement; 1985; 2(4):219-29. PubMed ID: 2937612
[TBL] [Abstract][Full Text] [Related]
5. Erythrocyte CR1 determination using monoclonal antibody in a microtiter plate ELISA; receptors are not masked by immune complexes.
Thomsen BS; Nielsen H; Bendixen G
Allergy; 1986 Sep; 41(7):479-86. PubMed ID: 2947511
[TBL] [Abstract][Full Text] [Related]
6. Interaction between immune complexes and C3b receptors on erythrocytes.
Yoshida K; Yukiyama Y; Miyamoto T
Clin Immunol Immunopathol; 1986 May; 39(2):213-21. PubMed ID: 2938857
[TBL] [Abstract][Full Text] [Related]
7. Does reduced erythrocyte C3b receptor (CR1) activity contribute to the pathogenesis of yersinia triggered reactive arthritis?
Lahesmaa R; Eerola E; Toivanen A
Ann Rheum Dis; 1992 Jan; 51(1):97-100. PubMed ID: 1531747
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative.
Kinoshita T; Takeda J; Hong K; Kozono H; Sakai H; Inoue K
J Immunol; 1988 May; 140(9):3066-72. PubMed ID: 2966205
[TBL] [Abstract][Full Text] [Related]
9. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.
Ng YC; Schifferli JA; Walport MJ
Clin Exp Immunol; 1988 Mar; 71(3):481-5. PubMed ID: 2968204
[TBL] [Abstract][Full Text] [Related]
10. 15-HETE "modulates" expression of C3b receptor (CR1) antigen on peripheral blood B-lymphocytes.
Cook J; Delebassée S; Aldigier JC; Gualde N; Kazatchkine M
Prostaglandins Leukot Med; 1986 Aug; 23(2-3):201-6. PubMed ID: 2429332
[TBL] [Abstract][Full Text] [Related]
11. Defective complement receptors (CR1 and CR3) on erythrocytes and leukocytes of factor I (C3b-inactivator) deficient patients.
Porteu F; Fischer A; Descamps-Latscha B; Halbwachs-Mecarelli L
Clin Exp Immunol; 1986 Nov; 66(2):463-71. PubMed ID: 2949901
[TBL] [Abstract][Full Text] [Related]
12. Identification of human erythrocyte blood group antigens on the C3b/C4b receptor.
Rao N; Ferguson DJ; Lee SF; Telen MJ
J Immunol; 1991 May; 146(10):3502-7. PubMed ID: 1827486
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the human glomerular C3 receptor as the C3b/C4b complement type one (CR1) receptor.
Fischer E; Appay MD; Cook J; Kazatchkine MD
J Immunol; 1986 Feb; 136(4):1373-7. PubMed ID: 2418113
[TBL] [Abstract][Full Text] [Related]
14. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].
Pascual M; Schifferli JA
Schweiz Med Wochenschr; 1993 Jan; 123(3):39-43. PubMed ID: 8426946
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of C3b receptor (CR1) on erythrocytes of patients with systemic lupus erythematosus contrasts with its normal expression in other systemic diseases and does not correlate with the occurrence or severity of SLE nephritis.
Jouvin MH; Wilson JG; Bourgeois P; Fearon DT; Kazatchkine MD
Complement; 1986; 3(2):88-96. PubMed ID: 2945697
[TBL] [Abstract][Full Text] [Related]
16. Rapid purification of the human C3b/C4b receptor (CR1) by monoclonal antibody affinity chromatography.
Wong WW; Jack RM; Smith JA; Kennedy CA; Fearon DT
J Immunol Methods; 1985 Oct; 82(2):303-13. PubMed ID: 2931485
[TBL] [Abstract][Full Text] [Related]
17. Erythrocyte enhancement of C3b-mediated phagocytosis by human neutrophils in vitro: a combined effect of the erythrocyte complement receptors CR1 and erythrocyte scavengers to reactive oxygen metabolites (ROM).
Forslid J; Hed J; Stendahl O
Immunology; 1985 May; 55(1):97-103. PubMed ID: 3158597
[TBL] [Abstract][Full Text] [Related]
18. Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1).
Madi N; Paccaud JP; Steiger G; Schifferli JA
Clin Exp Immunol; 1991 Apr; 84(1):9-15. PubMed ID: 1826650
[TBL] [Abstract][Full Text] [Related]
19. Interaction of complement-solubilized immune complexes (IC) with CR1 receptors on human erythrocytes. Polysulfated compounds inhibit IC binding and induce IC-release from CR1.
Jepsen HH; Ekre HP; Svehag SE
Int J Immunopharmacol; 1987; 9(5):587-95. PubMed ID: 2442111
[TBL] [Abstract][Full Text] [Related]
20. C3b receptor (CR1) on erythrocytes and the HLA-DR3 antigen.
Malaise M; Desoroux A; Mahieu P; Franchimont P
Arthritis Rheum; 1986 Feb; 29(2):300-1. PubMed ID: 2937410
[No Abstract] [Full Text] [Related]
[Next] [New Search]
